We are live on ! Find out more

Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
ALDX icon
426
Aldeyra Therapeutics
ALDX
$33.8M
$33.8M $0.5603 15%
IRLA
427
IRulya Therapeutics Inc. Common Stock
IRLA
$33.5M
$33.5M $32.95 4.21%
ACET icon
428
Adicet Bio
ACET
$32M
$32M $3.42 4.47%
FLNA icon
429
Filana Therapeutics
FLNA
$30M
$30M $0.6220 5.47%
EYPT icon
430
EyePoint Inc
EYPT
$30M
$30M $0.3484 8.32%
ALGS icon
431
Aligos Therapeutics
ALGS
$30M
$30M $4.80 4.57%
AARD icon
432
Aardvark Therapeutics
AARD
$29.8M
$29.8M $1.36 5.56%
PMN icon
433
ProMIS Neurosciences
PMN
$29.7M
$29.7M $3.31 70.1%
MGX icon
434
Metagenomi Therapeutics
MGX
$29.5M
$29.5M $0.7803 6.01%
NXTC icon
435
NextCure
NXTC
$28.9M
$28.9M $6.31 3.37%
ESLA icon
436
Estrella Immunopharma
ESLA
$27.8M
$27.8M $0.6393 12.3%
RNAZ icon
437
TransCode Therapeutics
RNAZ
$27.6M
$27.6M $1.63 5.78%
ABVC icon
438
ABVC BioPharma
ABVC
$26.7M
$26.7M $1 3.85%
BCTX icon
439
Briacell Therapeutics
BCTX
$26.5M
$26.5M $3.04 8.16%
BYSI icon
440
BeyondSpring
BYSI
$26.5M
$26.5M $0.6438 24.6%
EVAX icon
441
Evaxion A/S
EVAX
$26.4M
$26.4M $2.93 4.87%
PLRZ icon
442
Polyrizon Ltd
PLRZ
$26.1M
$26.1M $10.75 19.4%
CELU icon
443
Celularity
CELU
$26M
$26M $0.8001 5.79%
EDSA icon
444
Edesa Biotech
EDSA
$24.8M
$24.8M $2.57 4.81%
CRVO icon
445
CervoMed
CRVO
$24.2M
$24.2M $1.60 8.57%
IMNN icon
446
Imunon
IMNN
$23.3M
$23.3M $0.9100 9.24%
IMMP
447
Immutep
IMMP
$22.5M
$22.5M $3.06 8.11%
QNRX icon
448
Quoin Pharmaceuticals
QNRX
$21.8M
$21.8M $4.54 9.4%
ATOS icon
449
Atossa Therapeutics
ATOS
$21.7M
$21.7M $2.17 2.69%
BSEM icon
450
BioStem Technologies
BSEM
$20.9M
$20.9M $1.12 13.2%
16 17
18
19 20

Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 570 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.31T.

The largest by market cap are Vertex Pharmaceuticals (VRTX) at $142B, Regeneron Pharmaceuticals (REGN) at $96B and Moderna (MRNA) at $88.5B.

Among institutional investors, Revolution Medicines (RVMD) drew the most net new fund positions in Q2 2026: 246 funds opened new positions, taking total fund holders up 181 (35%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.